-+ 0.00%
-+ 0.00%
-+ 0.00%

EQUILLIUM INC - FDA OPEN TO EVALUATING LONGER TERM OUTCOMES FOR ITOLIZUMAB

Reuters·04/24/2025 13:06:38

Please log in to view news